<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font19 { font-size : 19; } .font22 { font-size : 22; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font22">and </span>
   <span class="font19">remdesivir </span>
   <span class="font15">with </span>
   <span class="font14">for </span>
   <span class="font14">The </span>
   <span class="font13">patients </span>
   <span class="font13">COVID- </span>
   <span class="font13">was </span>
   <span class="font13">clinical </span>
   <span class="font12">against </span>
   <span class="font12">{background </span>
   <span class="font12">that </span>
   <span class="font12">efficacy </span>
   <span class="font12">treatment </span>
   <span class="font12">al. </span>
   <span class="font12">margin </span>
   <span class="font12">severe </span>
   <span class="font11">{border-style </span>
   <span class="font11">not </span>
   <span class="font11">px;} </span>
   <span class="font11">were </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">;():â€". </span>
   <span class="font11">are </span>
   <span class="font11">trial </span>
   <span class="font11">coronavirus </span>
   <span class="font11">from </span>
   <span class="font11">virus </span>
   <span class="font11">Remdesivir </span>
   <span class="font11">into </span>
   <span class="font11">nucleoside </span>
   <span class="font11">study </span>
   <span class="font11">Ebola </span>
   <span class="font11">RNA </span>
   <span class="font11">respiratory </span>
   <span class="font11">viral </span>
   <span class="font11">disease </span>
   <span class="font11">drug </span>
   <span class="font11">safety </span>
   <span class="font11">COVID-. </span>
   <span class="font11">hospitalized </span>
   <span class="font11">therapeutic </span>
   <span class="font11">using </span>
   <span class="font11">NCT </span>
   <span class="font11">National </span>
   <span class="font11">SARS-CoV- </span>
   <span class="font11">administration </span>
   <span class="font11">antiviral </span>
   <span class="font11">intravenous </span>
   <span class="font11">randomized, </span>
   <span class="font10">Clinical </span>
   <span class="font10">analog </span>
   <span class="font10">first </span>
   <span class="font10">has </span>
   <span class="font10">may </span>
   <span class="font10">this </span>
   <span class="font10">trials </span>
   <span class="font10">(ClinicalTrials.gov </span>
   <span class="font10">Accessed </span>
   <span class="font10">Available </span>
   <span class="font10">active </span>
   <span class="font10">coronaviruses </span>
   <span class="font10">days </span>
   <span class="font10">from: </span>
   <span class="font10">phase </span>
   <span class="font10">replication </span>
   <span class="font10">â€" </span>
   <span class="font10">(GS-) </span>
   <span class="font10">.collab: </span>
   <span class="font10">Med. </span>
   <span class="font10">Trials </span>
   <span class="font10">effective </span>
   <span class="font10">evaluate </span>
   <span class="font10">infection </span>
   <span class="font10">novel </span>
   <span class="font10">placebo </span>
   <span class="font10">prodrug </span>
   <span class="font10">px; </span>
   <span class="font10">showed </span>
   <span class="font10">triphosphate </span>
   <span class="font10">{font-family </span>
   <span class="font10">-day </span>
   <span class="font10">For </span>
   <span class="font10">GS- </span>
   <span class="font10">Library </span>
   <span class="font10">Medicine </span>
   <span class="font10">acute </span>
   <span class="font10">adenosine </span>
   <span class="font10">double-blind, </span>
   <span class="font10">font-size </span>
   <span class="font10">polymerase </span>
   <span class="font10">received </span>
   <span class="font10">remdesivir. </span>
   <span class="font10">studies </span>
   <span class="font10">therapeutics </span>
   <span class="font10">time </span>
   <span class="font10">use </span>
   <span class="font10">vitro </span>
   <span class="font10">who </span>
   <span class="font10">Engl </span>
   <span class="font10">MERS </span>
   <span class="font10">Medical </span>
   <span class="font10">RNA-dependent </span>
   <span class="font10">Registry. </span>
   <span class="font10">Results </span>
   <span class="font10">U.S. </span>
   <span class="font10">animal </span>
   <span class="font10">both </span>
   <span class="font10">data </span>
   <span class="font10">day </span>
   <span class="font10">double; </span>
   <span class="font10">enzyme </span>
   <span class="font10">human </span>
   <span class="font10">infected </span>
   <span class="font10">inhibits </span>
   <span class="font10">mechanical </span>
   <span class="font10">options </span>
   <span class="font10">other </span>
   <span class="font10">oxygen </span>
   <span class="font10">phosphoramidate </span>
   <span class="font10">syndrome </span>
   <span class="font10">than </span>
   <span class="font10">treat </span>
   <span class="font10">ventilation </span>
   <span class="font10">(COVID-) </span>
   <span class="font10">Diseases </span>
   <span class="font10">However, </span>
   <span class="font10">Patients </span>
   <span class="font10">Research </span>
   <span class="font10">SARS-CoV-. </span>
   <span class="font10">about </span>
   <span class="font10">activity </span>
   <span class="font10">adult </span>
   <span class="font10">along </span>
   <span class="font10">and/or </span>
   <span class="font10">any </span>
   <span class="font10">authors </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">cells </span>
   <span class="font10">compared </span>
   <span class="font10">days. </span>
   <span class="font10">doi:./NEJMoa </span>
   <span class="font10">form </span>
   <span class="font10">https://clinicaltrials.gov/ct/show/NCT. </span>
   <span class="font10">identifier: </span>
   <span class="font10">improved </span>
   <span class="font10">improvement </span>
   <span class="font10">incorporated </span>
   <span class="font10">lung </span>
   <span class="font10">multicenter </span>
   <span class="font10">placebo-controlled </span>
   <span class="font10">prophylactic </span>
   <span class="font10">published </span>
   <span class="font10">randomly </span>
   <span class="font10">recovery </span>
   <span class="font10">solid; </span>
   <span class="font10">some </span>
   <span class="font10">treated </span>
   <span class="font10">without </span>
   <span class="font10">work </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(Figure </span>
   <span class="font10">(GS-â"¢) </span>
   <span class="font10">C-nucleoside </span>
   <span class="font10">China </span>
   <span class="font10">Coronavirus </span>
   <span class="font10">Disease </span>
   <span class="font10">Drug </span>
   <span class="font10">Institute </span>
   <span class="font10">NCT) </span>
   <span class="font10">NCT). </span>
   <span class="font10">Recruiting </span>
   <span class="font10">Sci </span>
   <span class="font10">United </span>
   <span class="font10">adults </span>
   <span class="font10">after </span>
   <span class="font10">associated </span>
   <span class="font10">available </span>
   <span class="font10">been </span>
   <span class="font10">bold </span>
   <span class="font10">cannot </span>
   <span class="font10">coronaviruses. </span>
   <span class="font10">courier; </span>
   <span class="font10">decreased </span>
   <span class="font10">dexamethasone </span>
   <span class="font10">did </span>
   <span class="font10">divided </span>
   <span class="font10">dose </span>
   <span class="font10">em; </span>
   <span class="font10">have </span>
   <span class="font10">included </span>
   <span class="font10">including </span>
   <span class="font10">infectious </span>
   <span class="font10">information </span>
   <span class="font10">invasive </span>
   <span class="font10">moderate </span>
   <span class="font10">more </span>
   <span class="font10">needing </span>
   <span class="font10">number: </span>
   <span class="font10">participants </span>
   <span class="font10">patient </span>
   <span class="font10">patients, </span>
   <span class="font10">placebo-controlled, </span>
   <span class="font10">pt;} </span>
   <span class="font10">results </span>
   <span class="font10">rhesus </span>
   <span class="font10">sequence </span>
   <span class="font10">significant </span>
   <span class="font10">subjects </span>
   <span class="font10">such </span>
   <span class="font10">time, </span>
   <span class="font10">vitro. </span>
  </p>
 </body>
</html>
